trial · primary record
Gemcitabine
Bladder Cancer
| Phase | Phase 2 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 1 |
| Primary completion | 2026-01-05 |
| Primary endpoint | Clinical Complete Response |
| Registry ID | NCT06571708 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:46.716Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06571708
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.